Nicholas Locantore

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

John R. Hurst, Jørgen Vestbo, Antonio Anzueto et al. · New England Journal of Medicine · 2010 · 2.9K citations · Full text

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 722 citations

Blood Eosinophil Counts, Allergy, Inflammatory Lung Disease +7

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

Bartolomé R. Celli, Nicholas Locantore, Julie Yates et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 423 citations

Robust principal component analysis for functional data

Nicholas Locantore, J. S. Marron, Douglas G. Simpson et al. · Test · 1999 · 358 citations

Engineering, Robust Statistic, Functional Data +5

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 323 citations